Possibilities of flow cytometric minimal residual disease monitoring in multiple myeloma.
| Authors | |
|---|---|
| Year of publication | 2017 |
| Type | Conference abstract |
| Citation | |
| Related projects: |
| Authors | |
|---|---|
| Year of publication | 2017 |
| Type | Conference abstract |
| Citation | |
| Related projects: |